Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study

Area of Science:

• Nephrology
• Critical Care Medicine
• Pharmacology

Background:

• Acute continuous hemodiafiltration (ACHD) requires effective anticoagulation to maintain extracorporeal circuit patency.
• Heparin-based regimens are commonly used, but optimal strategies require further elucidation.

Purpose of the Study:

• To compare the efficacy of different heparin anticoagulation regimens in ACHD.
• To evaluate filter survival rates across various ACHD modalities and anticoagulation protocols.

Main Methods:

• Prospective, controlled, randomized comparisons of low-dose heparin versus regional anticoagulation or no anticoagulation.
• Study included patients undergoing continuous arteriovenous hemodiafiltration (CAVHD) via shunt or femoral cannulae, and continuous veno-venous hemodiafiltration (CVVHD).
• Assessment of filter survival and hemorrhagic complications.

Main Results:

• Regional anticoagulation significantly prolonged filter survival in shunt CAVHD compared to low-dose heparin (57.1h vs 42.9h).
• No significant difference in filter survival was observed between low-dose heparin and no anticoagulation in femoral CAVHD (55h vs 52.5h).
• CVVHD showed similar filter survival with regional anticoagulation and low-dose heparin (40.5h vs 31.4h), and adequate survival without anticoagulation in high-risk bleeding patients (40.9h).

Conclusions:

• Regional anticoagulation is superior to low-dose heparin for filter survival in shunt CAVHD.
• Heparin and no anticoagulation yield comparable filter survival in femoral CAVHD.
• Low-dose heparin and regional anticoagulation offer similar filter survival in CVVHD.
• Anticoagulation-free CVVHD is a viable option for high-risk bleeding patients.